Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

Some of the PBMs named by the FTC said in statements that the government's action showed that it does not understand how drug ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

Novo Nordisk NVO shares have lost 5% in the past three months, which translates to approximately $29 billion in market value, ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...